Table 1. Baseline characteristics of study participants.

	Panobinostat	Vorinostat
No. of male participants	15	14
No. of female participants	0	1
Age (years)*	47 (28–53)	48 (40–56)
Virological suppression (years)*	3.6 (2.5–16.0)	5.0 (2.7–11.0)
Baseline CD4 (cells per μl)*	935 (615–1,990)	717 (479–1,136)
No. treated during acute infection	3	1
No. of sequences analysed	2,843	1,654

CD4, CD4⁺ T cell.

^*Values represent median (range).